GSHR 10-K & 10-Q changes, risk factors and insider trading
Gesher Acquisition Corp. II (also GSHRU, GSHRW) · Nasdaq · Blank Checks · CIK 2044635 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Comparison not available: Not available: fewer than two 10-K filings on EDGAR to compare (only one so far)..
What changed in the latest 10-Q
Risk Factors
As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. However, for detailed descriptions of the risks relating to our Company, see the section titled “Risk Factors” contained in our (i) IPO Registration Statement, (ii) 2025 Annual Report, (iii) 2025 Q1 Form 10-Q and (iv) 2025 Q2 Form 10-Q. As of the date of this Report, there have been no material changes with respect to those risk factors. Any of these previously disclosed risk factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risks not presently known to us or that we currently deem immaterial may also affect our ability to consummate an initial Business Combination. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
“Our liquidity needs through March 24, 2025 were satisfied through (i) a contribution of $25,000 from the Sponsor in exchange for the issuance of our Founder Shares and (ii) a loan pursuant to the IPO Promissory Note. Following the Initial Public Offering and the Private Placement, our liquidity needs through June 30, 2026 have been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside the Trust Account.”see in full comparison
“Our liquidity needs through March 31, 2026 have been satisfied through (i) a contribution of $25,000 from the Sponsor in exchange for the issuance of our Founder Shares, (ii) a loan pursuant to the IPO Promissory Note and (iii) the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside the Trust Account.”see in full comparison
“Furthermore, pursuant to the Letter Agreement, our Sponsor, directors and officers have agreed that: …”see in full comparison
“In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us Working Capital Loans as may be required. If we complete a Business Combination, we will repay such Working Capital Loans. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such Working Capital Loans, but no proceeds from our Trust Account will be used for such repayment. …”see in full comparison
“In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us Working Capital Loans as may be required. If we complete a Business Combination, we will repay such Working Capital Loans. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such Working Capital Loans, but no proceeds from our Trust Account would be used for such repayment. …”see in full comparison
“Prior to the closing of our Initial Public Offering, our Sponsor agreed to loan us an aggregate of up to $300,000 to be used for a portion of the expenses of the Initial Public Offering pursuant to the IPO Promissory Note. The loan was non-interest bearing, unsecured and due at the earlier of May 31, 2025, or the closing of the Initial Public Offering. On March 24, 2025, we repaid the total outstanding balance of the IPO Promissory Note amounting to $162,616. Borrowings under the IPO Promissory Note are no longer available.”see in full comparison
Full comparison: every changed paragraph (22)
All statements other than statements of historical
fact included in this Report including, without limitation, statements under this Item regarding our financial position, possible Business
Combinations and the financing thereof, and related matters, and the plans and objectives of Management for future operations, are forward-looking
statements- within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. When used in this Report, words
such as “may,” “should,” “could,” “would,” “anticipate,” “believe,”
“estimate,” “expect,” “intend” and similar expressions, as they relate to us or our Management, identify
forward-looking statements. We have based these forward-looking statements on our Management’s current expectations and projections
about future events, as well as assumptions made by, and information currently available to, our Management. Actual results could differ
materially from those contemplated by thesuch forward-looking statements as a result of certain factors detailed in our filings with the SEC.
SEC, including herein. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety
by this paragraph.
We have neither engaged in any operations nor
generated any revenues to date. Our only activities since August 29, 2024 (inception) through MarchJune 31,30, 2026 have been (i) organizational
activities and (ii) activities relating to (x) the Initial Public Offering and (y) identifying and evaluating prospective acquisition
candidates and activities in connection with the initial Business Combination. We will not generate any operating revenues until after
completion of our initial Business Combination. We have generated non-operating income in the form of interest income on investments held
in the Trust Account after the Initial Public Offering. We expect to incur increased expenses as a result of being a public company (for
legal, financial reporting, accounting and auditing compliance, among other things), as well as for due diligence expenses.
For the three months ended MarchJune 31,30, 2026, we
had a net income of $891,601,$944,152, which consists of interest earned on marketable securities held in the Trust Account of $1,304,269,$1,318,684, offset
by operating costs of $412,668.$374,532.
For the three months ended MarchJune 31,30, 2025, we
had a net income of $29,499,$1,316,265, which consists of operating costs of $84,174, offset by interest income on cash and marketable securities
held in the Trust Account of $113,673.$1,497,409, offset by operating costs of $181,144.
For the six months ended June 30, 2026, we had a net income of $1,835,753, which consists of interest earned on marketable securities held in the Trust Account of $2,622,953, offset by operating costs of $787,200.
For the six months ended June 30, 2025, we had a net income of $1,345,764, which consists of interest income on cash and marketable securities held in the Trust Account of $1,611,082, offset by operating costs of $265,318.
Our liquidity needs through March 24, 2025 were satisfied through (i) a contribution of $25,000 from the Sponsor in exchange for the issuance of our Founder Shares and (ii) a loan pursuant to the IPO Promissory Note. Following the Initial Public Offering and the Private Placement, our liquidity needs through June 30, 2026 have been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside the Trust Account.
For the threesix months ended MarchJune 31,30, 2026, net
cash used in operating activities was $503,926.$702,709. Net income of $891,601$1,835,753 was impacted by the interest earned on marketable securities held
in the Trust Account of $1,304,269.$2,622,953. Changes in operating assets and liabilities provided $91,258$84,491 of cash from operating activities.
For the threesix months ended MarchJune 31,30, 2025, cash
used in operating activities was $231,741.$395,246. Net income of $29,499$1,345,764 was affected by interest earned on cash and marketable securities held
in the Trust Account of $113,673$1,611,082 and payment of operation costs through promissorythe noteIPO Promissory Note of $37,574. Changes in operating assets and liabilities
used $185,141$167,502 of cash for operating activities.
As of MarchJune 31,30, 2026, we had marketable securities
held in the Trust Account of $150,028,760$151,347,444 (including $1,304,269$7,166,194 of interest income). We may withdraw interest from the Trust Account to
pay taxes, if any. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest
earned on the Trust Account (which interest shall be net of income taxes payable, if any, and exclude the Deferred Fee), to complete our
Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business
Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target
business or businesses, make other acquisitions and pursue our growth strategies.
To mitigate the risk that we might be deemed to
be an investment company for purposes of the Investment Company Act, which risk increases the longer that we hold investments in the Trust
Account, we may, at any time (based on our Management Team’s ongoing assessment of all factors related to our potential status under
the Investment Company Act), instruct the trusteeContinental to liquidate the investments held in the Trust Account and instead to hold the funds
in the Trust Account in cash or in an interest-bearing demand deposit account at a bank.
As of MarchJune 31,30, 2026, we had cash held outside
of the Trust Account of approximately $589,283.$310,500. We use the funds held outside the Trust Account primarily to identify and evaluate target
businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants, or similar locations
of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective
target businesses, and structure, negotiate and complete a Business Combination.
Prior to the closing of our Initial Public Offering, our Sponsor agreed to loan us an aggregate of up to $300,000 to be used for a portion of the expenses of the Initial Public Offering pursuant to the IPO Promissory Note. The loan was non-interest bearing, unsecured and due at the earlier of May 31, 2025, or the closing of the Initial Public Offering. On March 24, 2025, we repaid the total outstanding balance of the IPO Promissory Note amounting to $162,616. Borrowings under the IPO Promissory Note are no longer available.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us Working Capital Loans as may be required. If we complete a Business Combination, we will repay such Working Capital Loans. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such Working Capital Loans, but no proceeds from our Trust Account will be used for such repayment. Up to $1,500,000 of such Working Capital Loans may be converted into units of the post-Business Combination entity at a price of $10.00 per unit. Such units (and underlying securities) would be identical to the Private Placement Units (and underlying securities). Other than as set forth above, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such Working Capital Loans. As of June 30, 2026, we did not have any borrowings under any Working Capital Loans.
Our liquidity needs through March 31, 2026 have
been satisfied through (i) a contribution of $25,000 from the Sponsor in exchange for the issuance of our Founder Shares, (ii) a loan
pursuant to the IPO Promissory Note and (iii) the net proceeds from the consummation of the Initial Public Offering and the Private Placement
held outside the Trust Account.
Prior to the closing of our Initial Public Offering,
our Sponsor agreed to loan us an aggregate of up to $300,000 to be used for a portion of the expenses of the Initial Public Offering pursuant
to the IPO Promissory Note. The loan was non-interest bearing, unsecured and due at the earlier of May 31, 2025 or the closing of the
Initial Public Offering. On March 24, 2025, we repaid the total outstanding balance of the IPO Promissory Note amounting to $162,616.
Borrowings under the IPO Promissory Note are no longer available.
In order to fund working capital deficiencies
or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their
affiliates may, but are not obligated to, loan us Working Capital Loans as may be required. If we complete a Business Combination, we
will repay such Working Capital Loans. In the event that a Business Combination does not close, we may use a portion of the working capital
held outside the Trust Account to repay such Working Capital Loans, but no proceeds from our Trust Account would be used for such repayment.
Up to $1,500,000 of such Working Capital Loans may be converted into units of the post-Business Combination entity at a price of $10.00
per unit. The units (and underlying securities) would be identical to the Private Placement Units (and underlying securities). Other than
as set forth above, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect
to such Working Capital Loans. As of March 31, 2026, we did not have any borrowings under any Working Capital Loans.
Commencing on March 21, 2025, and until the completion
of our Business Combination or liquidation, we reimburse an affiliate of the Sponsor $10,000 per month for office space, utilities, and
secretarial and administrative support pursuant to the Administrative Services Agreement and; $6,000 of which was used as compensation
to Mr. Sagi Dagan, our former Chief Financial Officer, for the year ended December 31, 2025.
Since inception, the Company has incurred aggregate
fees of $120,000$150,000 under the Administrative Services Agreement, of which $66,806$95,708 had been paid as of MarchJune 31,30, 2026, resulting in an accrued
expense balance of $53,194$54,292 as of MarchJune 31,30, 2026. For the three and six months ended MarchJune 31,30, 2026, the Company incurred $30,000 and $60,000, respectively, of fees under
the Administrative Services Agreement. For the three and six months ended MarchJune 31,30, 2025, the Company didincurred not$30,000 incurunder anythe paymentAdministrative forServices these services.Agreement.
Furthermore, pursuant to the Letter Agreement, our Sponsor, directors and officers have agreed that: (x) the Founder Shares shall be subject to a transfer restrictions of the earlier of (i) one year after the completion of our initial Business Combination or earlier if, subsequent to our initial Business Combination, the closing price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial Business Combination and (ii) the date following the completion of our initial Business Combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property, (y) the Private Placement Units (including their underlying securities) shall be subject to transfer restriction until 30 days after the completion of our initial Business Combination and (z) any Units, Warrants, Ordinary Shares or any other securities convertible into, or exercisable or exchangeable for, any Units, Ordinary Shares or Warrants were subject to transfer restriction for 180 days following the filing of the prospectus for the Initial Public Offering.
The preparation of the unaudited condensed financial
statements and notes thereto included in this Report under Item 1. “Financial Statements” in conformity with GAAP requires
Management to make estimates and assumptions that affect the reported amounts of assets and liabilities, income and expenses, and the
disclosure of contingent assets and liabilities, in our unaudited condensed financial statements. These accounting estimates require the
use of assumptions about matters, some of which are highly uncertain at the time of estimation. Management bases its estimates on historical
experience and on various other assumptions it believes to be reasonable under the circumstances, the results of which form the basis
for making judgments, and we evaluate these estimates on an ongoing basis. To the extent actual experience differs from the assumptions
used, our unaudited condensed financial statements and notes thereto included in this Report under Item 1. “Financial Statements”
could be materially affected. We believe that the following accounting policies involve a higher degreeAs of judgmentJune and complexity. As
of March 31,30, 2026, we did not have any critical accounting estimates to be disclosed.
In November 2024, the FASB issued ASU Topic 2024-03,
“Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income
Statement Expenses” (“ASU 2024-03”), requiring public entities to disclose additional information about specific expense
categories in the notes to the unaudited condensed financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal
years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. We
are currently evaluating the impact of adopting ASU 2024-03.
GSHR insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding GSHR (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 453,124 | $4.7M | 0.0% | No change |
| D. E. Shaw & Co. | 2026-06-30 | 430,565 | $4.5M | 0.0% | Added 39% |
| D. E. Shaw & Co. | 2026-06-30 | 75,000 | $21.0K | 0.0% | No change |